April 10, 2026
Vivatides Therapeutics
Vivatides Therapeutics develops RNA treatments to...
- Round
- Series A
- Amount raised
- $54M
- Lead investor
- Apricot Capital
- Industry
- Biotechnology
- Headquarters
- Woburn, United States
- Employees
- 1-10
- Website
- —
- —
Other investors
- Qiming Venture